Propanc Biopharma Valuation
| PPCB Stock | USD 0.0003 0.0001 50.00% |
Propanc Biopharma seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Propanc Biopharma from analyzing the company fundamentals such as Return On Asset of -13.07, ebitda of (2.14 M), and Shares Owned By Insiders of 1.60 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Propanc Biopharma's price fluctuation is out of control at this time. Calculation of the real value of Propanc Biopharma is based on 3 months time horizon. Increasing Propanc Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Propanc Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Propanc Pink Sheet. However, Propanc Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.0E-4 | Real 2.69E-4 | Hype 1.96E-4 |
The real value of Propanc Pink Sheet, also known as its intrinsic value, is the underlying worth of Propanc Biopharma Company, which is reflected in its stock price. It is based on Propanc Biopharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Propanc Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Propanc Biopharma helps investors to forecast how Propanc pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Propanc Biopharma more accurately as focusing exclusively on Propanc Biopharma's fundamentals will not take into account other important factors: Propanc Biopharma Total Value Analysis
Propanc Biopharma is at this time forecasted to have valuation of 1.53 M with market capitalization of 705.56 K, debt of 1.1 M, and cash on hands of 4.07 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Propanc Biopharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.53 M | 705.56 K | 1.1 M | 4.07 K |
Propanc Biopharma Asset Utilization
One of the ways to look at asset utilization of Propanc is to check how much profit was generated for every dollar of assets it reports. Propanc Biopharma holds a negative application of assets of -13.07 pct., losing $0.13 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Propanc Biopharma shows how discouraging it operates for each dollar spent on its assets.Propanc Biopharma Ownership Allocation
Propanc Biopharma owns a total of 1.76 Billion outstanding shares. Roughly 98.4 pct. of Propanc Biopharma outstanding shares are held by general public with 1.6 % owned by insiders and only 0.0 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Propanc Biopharma Profitability Analysis
Net Loss for the year was (2.66 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Propanc Biopharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Propanc Biopharma and how it compares across the competition.
About Propanc Biopharma Valuation
The pink sheet valuation mechanism determines Propanc Biopharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Propanc Biopharma. We calculate exposure to Propanc Biopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Propanc Biopharma's related companies.Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia. Propanc Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Propanc Biopharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Propanc Biopharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Propanc Biopharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Propanc Biopharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Propanc Biopharma's revenue streams: Identify Propanc Biopharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Propanc Biopharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Propanc Biopharma's growth potential: Evaluate Propanc Biopharma's management, business model, and growth potential.
- Determine Propanc Biopharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Propanc Biopharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Propanc Biopharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 220.4 M | |
| Retained Earnings | -61.6 M |
Complementary Tools for Propanc Pink Sheet analysis
When running Propanc Biopharma's price analysis, check to measure Propanc Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Propanc Biopharma is operating at the current time. Most of Propanc Biopharma's value examination focuses on studying past and present price action to predict the probability of Propanc Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Propanc Biopharma's price. Additionally, you may evaluate how the addition of Propanc Biopharma to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |